Key Trends from the 2024 J.P. Morgan Healthcare Conference
Key trends such as the resilience of the emerging biopharma space, the complexities of Medicare, and the revolutionary role of data and AI are shaping the future of the industry.
Industry execs forecast the year ahead for gene therapy at Biotech Showcase
Hospitals - especially in Europe - anticipate growing interest from international patients. But a wave of industry consolidation is debatable.
The Funding Model for Cancer Innovation is Broken — We Can Fix It
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
At JPM, French investment banker to U.S. biotech/medtech investors: Stop by Paris. There’s money to be made here
A French investment banker attempts to explain how the new France is a haven for startups and biotech innovation, and a place where U.S. investors stand to make a ton of money.